Get started
Author

Kenta Kevee Kisaï

Observed names: Kenta Kisai, Kenta Kisaï
ORCID: 0000-0002-8046-9276
Observed ORCID: 0000-0002-8046-9276
OpenAlex ID: A5085960343
Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms
2024 · Tomohiko Sato, Kenichi Yoshida, et al. · Blood · 34
Prognostic role of USP7 expression in cancer patients: A systematic review and meta-analysis
2021 · Kenta Kisaï, Shinsaku Koji · Pathology - Research and Practice · 15
PDF
Model-based quantification of protein–protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels
2026 · Kenta Kevee Kisaï, Takashi Omori · BMC Bioinformatics
Model-based quantification of protein–protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels
2026 · Kenta Kevee Kisaï, Takashi Omori · Figshare
Additional file 3 of Model-based quantification of protein–protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels
2026 · Kenta Kevee Kisaï, Takashi Omori · Figshare
Additional file 1 of Model-based quantification of protein–protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels
2026 · Kenta Kevee Kisaï, Takashi Omori · Figshare
Additional file 2 of Model-based quantification of protein–protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels
2026 · Kenta Kevee Kisaï, Takashi Omori · Figshare
Treatment patterns and clinical outcome in advanced/recurrent endometrial cancer after adjuvant chemotherapy: interim analysis of the JGOG2055s/PEACH study
2026 · Yosuke Okui, Yoshihito Yokoyama, et al. · International Journal of Gynecological Cancer
Works count: 8
Citation count: 49
H-index: 2
I10-index: 2
Year
Topic
Type